Statins for primary prevention of venous thromboembolism
Information
- DOI:
- https://doi.org/10.1002/14651858.CD008203.pub2Copy DOI
- Database:
-
- Cochrane Database of Systematic Reviews
- Version published:
-
- 07 December 2011see what's new
- Type:
-
- Intervention
- Stage:
-
- Review
- Cochrane Editorial Group:
-
Cochrane Vascular Group
- Copyright:
-
- Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Article metrics
Altmetric:
Cited by:
Authors
Contributions of authors
| Draft the protocol | Lun Li; JinHui Tian |
| Develop and run the search strategy | JinHui Tian |
| Obtain copies of studies | TianTian Sun; Peizhen Zhang |
| Select which studies to include (2 people) | Lun Li; JinHui Tian |
| Extract data from studies (2 people) | Lun Li; TianTian Sun |
| Enter data into RevMan | Lun Li; TianTian Sun; Peizhen Zhang |
| Carry out the analysis | JinHui Tian; Lun Li |
| Interpret the analysis | KeHu Yang; JinHui Tian |
| Draft the final review | Lun Li; JinHui Tian |
| Update the review | Lun Li; JinHui Tian |
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
Chief Scientist Office, Scottish Government Health Directorates, The Scottish Government, UK.
Declarations of interest
None known
Acknowledgements
The review authors would like to thank the following people for commenting on the review: Marlene Stewart who helped revise the full review, Heather Maxwell who helped revise the protocol, Peng Zhang and WenQin Jia who gave some useful advice for this systematic review.
Version history
| Published | Title | Stage | Authors | Version |
| 2014 Dec 18 | Statins for primary prevention of venous thromboembolism | Review | Lun Li, Peizhen Zhang, Jin Hui Tian, KeHu Yang | |
| 2011 Dec 07 | Statins for primary prevention of venous thromboembolism | Review | Lun Li, TianTian Sun, Peizhen Zhang, Jinhui Tian, KeHu Yang | |
| 2010 Jan 20 | Statins for prevention of venous thromboembolism | Protocol | Lun Li, Jin Hui Tian, Peizhen Zhang, TianTian Sun, Ke Hu Yang | |
Differences between protocol and review
In the Primary outcomes section, we added the definition of provoked and unprovoked VTE because we wanted to distinguish between them, for healthy users and patients. Also, we moved 'all cause mortality' to 'the rates of death'.
We moved 'the rates of cardiovascular and cerebrovascular events' and 'the rates of death' to the Secondary outcomes section to highlight that the primary outcome of this review is 'the rates of VTE (DVT and PE)' and that the included studies were selected for the assessment of VTE and not cardiovascular and cerebrovascular events.
We added 'serious adverse event (SAE)' to the Secondary outcomes section because we think this is an important outcome within the outcome of adverse events.
